RecruitingNCT03004326
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Sponsor
Peter Merkel
Enrollment
50 participants
Start Date
Jan 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
Eligibility
Min Age: 5 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with cryoglobulinemic vasculitis (cv), drug-induced vasculitis, and other related conditions. The study is currently recruiting participants at 10 locations. People eligible for this study include aged 5 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03004326
Related Trials
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
NCT04294771
Benralizumab Effectiveness in EGPA
NCT07815886
A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab
NCT07268521
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT0651288315 locations
A Randomized Multicenter Study for Isolated Skin Vasculitis
NCT0293957316 locations